Clinical Trial

Bad Berka Heart Rhythm Registry of Patients With or at Risk of Arrhythmias Treated at Heart Center Bad Berka

Study acronym: 2B2R
Recruiting
View on ClinicalTrials.gov →
Summary
The Bad Berka Heart Rhythm Registry (2B2R) is a prospective, single-center observational cohort designed to systematically collect and analyze data of patients undergoing cardiac arrhythmia therapy as well as implantation of cardiac electronic devices (CIEDs) at the Heart Center Bad Berka. The register aims to evaluate procedural safety, acute and long-term efficacy, and clinical outcomes across a broad spectrum of arrhythmias and interventional strategies, including novel technologies such as pulsed field ablation (PFA) and conduction system pacing. The registry is intended to generate real-world evidence to support clinical decision-making, identify predictors of outcomes, and contribute to quality assurance and innovation in the field of cardiac electrophysiology.
Trial Details
NCT Number NCT07020910
Lead Sponsor Zentralklinik Bad Berka
Conditions Cardiac Arrhythmias
Enrollment 5,000 participants
Start Date 2024-08-01
Primary Completion 2029-08-01 (estimated)
Study Completion 2034-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-13